{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458638230
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = o
| target = [[endotoxin]]
<!-- Clinical data -->
| tradename = 
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category = 
| legal_AU = 
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Intravenous therapy|Intravenous infusion]]
<!-- Pharmacokinetic data -->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 141410-98-2
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
<!-- Chemical data -->
| chemical_formula = 
| molecular_weight = 
}}
'''Edobacomab''', codenamed '''E5''', is a [[mouse]] [[monoclonal antibody]] that was investigated as a possible treatment for [[sepsis]] caused by [[Gram-negative bacteria]]l infections.

==Further reading==
*{{cite journal |author=Greenman RL |title=A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group |journal=JAMA |volume=266 |issue=8 |pages=1097–102 |date=August 1991 |pmid=1865542 |doi= 10.1001/jama.266.8.1097|url= |author2=Schein RM |author3=Martin MA |display-authors=3 |last4=Wenzel |first4=RP |last5=MacIntyre |first5=NR |last6=Emmanuel |first6=G |last7=Chmel |first7=H |last8=Kohler |first8=RB |last9=McCarthy |first9=M}}
*{{cite journal |author=Bone RC |title=A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group |journal=Crit. Care Med. |volume=23 |issue=6 |pages=994–1006 |date=June 1995 |pmid=7774238 |doi= 10.1097/00003246-199506000-00003|url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0090-3493&volume=23&issue=6&spage=994 |author2=Balk RA |author3=Fein AM |display-authors=3 |last4=Perl |first4=TM |last5=Wenzel |first5=RP |last6=Reines |first6=HD |last7=Quenzer |first7=RW |last8=Iberti |first8=TJ |last9=MacIntyre |first9=N}}
*{{cite journal |author=Angus DC |title=E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators |journal=JAMA |volume=283 |issue=13 |pages=1723–30 |date=April 2000 |pmid=10755499 |doi= 10.1001/jama.283.13.1723|url=http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=10755499 |author2=Birmingham MC |author3=Balk RA |display-authors=3 |last4=Scannon |first4=PJ |last5=Collins |first5=D |last6=Kruse |first6=JA |last7=Graham |first7=DR |last8=Dedhia |first8=HV |last9=Homann |first9=S}}

{{Monoclonals for infectious disease and toxins}}

[[Category:Monoclonal antibodies]]
[[Category:Abandoned drugs]]

{{antiinfective-drug-stub}}
{{monoclonal-antibody-stub}}